PK, PD and TK studies
We have many years of experience carrying out pharmacokinetic (PK), pharmacodynamics (PD) and toxicokinetic (TK) studies for all stages of drug development providing expertise and quality to our clients.
Support for preclinical and clinical studies
Our trained and experienced pharmacokineticists use industry standard WinNonLin™ application for non-compartmental analysis, giving you access to a complete bioanalytical pharmacokinetic/toxicokinetic (PK/TK) service to support your preclinical and clinical studies.
The application of pharmacokinetic/pharmacodynamics (PK/PD) modelling can allow answering critical questions during all phases of drug development, helping to maximize the information gained from an experiment, providing better understanding of the PK/PD of the drug, and allows for simulations in order to select future dosing regimens and optimal sampling strategies. This enables efficient, cost-effective and scientifically sound study designs that help get your drugs to market faster.
We can provide data in bespoke formats to meet you exact reporting needs with expert advice and interpretation. Our dedicated data management team allows us to provide data transfers and reporting to Clinical Data Interchange Standards Consortium (CDISC) specifications for the Exchange of Nonclinical Data (SEND) and Human Clinical Data (SDTM).